LabCorp Announces Appointment of Dr. Mark Elliott Brecher As Chief Medical Officer

BURLINGTON, N.C. --(BUSINESS WIRE)--Mar. 2, 2009-- Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE: LH) today announced the appointment of Dr. Mark Elliott Brecher as Chief Medical Officer. Dr. Brecher is a leader in the field of pathology, with research published in a wide variety

LabCorp is the First National Commercial Lab to Offer Roche's COBAS(R) AmpliPrep/COBAS(R) TaqMan(R) HCV Test

BURLINGTON, N.C. --(BUSINESS WIRE)--Feb. 12, 2009-- Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE:LH) announces that it is the first national clinical laboratory to offer HCV PCR testing using a newly FDA approved assay, the Roche COBAS® AmpliPrep/COBAS ® TaqMan ® HCV Test.

Laboratory Corporation of America(R) Holdings Announces 2008 Fourth Quarter and Full Year Results

Strong Revenue and Volume Growth Drive Adjusted EPS of $1.10 BURLINGTON, N.C. --(BUSINESS WIRE)--Feb. 12, 2009-- Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE: LH) today announced results for the quarter and year ended December 31, 2008 .

LabCorp is Scheduled to Present at the 27th Annual J.P. Morgan Healthcare Conference

BURLINGTON , N.C.--(BUSINESS WIRE)-- Jan. 9, 2009 --Laboratory Corporation of America (R) Holdings (LabCorp (R) ) (NYSE: LH) today announced that David P. King , Chief Executive Officer, is scheduled to speak at the 27 th Annual J.P. Morgan Healthcare Conference in San Francisco, CA .

LabCorp To Present at the Goldman Sachs Healthcare Conference - Reiterates 2008 Guidance and Updates Preliminary 2009 Guidance

BURLINGTON, N.C., Jan 06, 2009 (BUSINESS WIRE) -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that David P. King, Chief Executive Officer, is scheduled to speak at the Goldman Sachs Healthcare Conference in New York City, NY.

National Jewish Health and LabCorp to Collaborate on Companion Diagnostics Opportunities

DENVER & BURLINGTON, N.C., Dec 10, 2008 (BUSINESS WIRE) -- National Jewish Health and Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) (LabCorp) have reached an agreement to collaborate in the development and commercialization of molecular diagnostic tests in support of

LabCorp is Scheduled to Present at the 20th Annual Piper Jaffray Health Care Conference

BURLINGTON, N.C., Nov 24, 2008 (BUSINESS WIRE) -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that William B. (Brad) Hayes, Executive Vice President and Chief Financial Officer, is scheduled to speak at the 20th Annual Piper Jaffray Health Care Conference

LabCorp Launches Tumor MGMT Gene Methylation Testing

BURLINGTON, N.C., Nov 19, 2008 (BUSINESS WIRE) -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) announced today that it has introduced its MGMT gene methylation assay using Methylation-Specific PCR technology licensed from OncoMethylome Sciences (Euronext Brussels: ONCOB;

LabCorp is Scheduled to Present at the Credit Suisse 2008 Global Healthcare Conference

BURLINGTON, N.C.--(BUSINESS WIRE)--Nov. 7, 2008--Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that William B. (Brad) Hayes, Executive Vice President and Chief Financial Officer, is scheduled to speak at the Credit Suisse 2008 Global Healthcare Conference in

LabCorp to be the First National Commercial Lab to Offer Roche's COBAS(R) TaqMan(R) HBV Test

BURLINGTON, N.C., Nov 06, 2008 (BUSINESS WIRE) -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) announces that it will be the first national clinical laboratory to offer HBV PCR testing using a newly FDA approved assay, the Roche COBAS(R) TaqMan(R) HBV Test.